Guardant Health, Inc. (GH) stock
GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$154.86+0.08 (+0.05%)
Close on Nov 12, 2026Market cap $20.78BP/E –Yield –
Guardant Health statistics
83 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 18, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 15.45
- 1.67
Share statisticsIndustry
- Shares Change (YoY)
- 6.18%
- 2.40%
- Shares Change (QoQ)
- 0.83%
- 0.33%
- Float
- 132M
- 35M
- Shares Held by Insiders
- 1.83%
- 15.2%
- Shares Held by Institutions
- 99.8%
- 83.6%
Short sellingIndustry
- Short Interest
- 9M
- –
- Short Interest Change
- -19.2%
- -0.86%
- Short % of Float
- 7.16%
- 6.37%
- Short % of Shares Outstanding
- 7.03%
- 4.21%
- Days to Cover
- 5.38
- 4.41
Stock price statisticsIndustry
- 52-Week High
- $191.05
- –
- 52-Week Low
- $74.55
- –
- 20-Day Moving Average
- $165.91
- –
- 50-Day Moving Average
- $168.83
- –
- 200-Day Moving Average
- $132.58
- –
- Average True Range (14)
- $9.87
- –
- Price Change (1 Week)
- 0.93%
- -0.16%
- Price Change (1 Month)
- -4.99%
- 0.10%
- Price Change (3 Months)
- -1.49%
- 1.86%
- Price Change (6 Months)
- 57.0%
- 15.1%
- Price Change (YTD)
- 51.6%
- 5.96%
- Price Change (1 Year)
- 58.5%
- 8.30%
- Price Change (3 Years)
- 584.3%
- 20.9%
- Price Change (5 Years)
- 49.2%
- -13.8%
- Average Volume (10 Days)
- 3M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 1.63
- 0.77
- Relative Strength Index (14)
- 41.0
- 46.5
- Volatility (1 Year)
- 52.9%
- 63.0%
- Beta (5 Years)
- 1.62
- 0.77
MarginsIndustry
- Pretax Margin
- -38.0%
- 2.12%
- EBITDA Margin
- -36.3%
- 3.36%
- FCF Margin
- -18.2%
- 2.98%
Returns on capitalIndustry
- Return on Assets (ROA)
- -30.7%
- -3.06%
- Return on Capital Employed (ROCE)
- -33.3%
- 0.40%
Financial positionIndustry
- Current Ratio
- 3.60
- 1.41
- Quick Ratio
- 3.25
- 0.99
- Interest Coverage
- -96.60
- -0.63
GrowthIndustry
- Revenue Growth (YoY)
- 41.7%
- 9.63%
- Revenue Growth (3Y CAGR)
- 29.8%
- 11.3%
- Revenue Growth (5Y CAGR)
- 27.9%
- 12.6%
EfficiencyIndustry
- Asset Turnover
- 0.81
- 0.81
- Inventory Turnover
- 4.84
- 10.99
- Revenue Per Employee
- $510.33K
- $235.26K
- Profits Per Employee
- -$193.57K
- -$5.12K
- Employee Count
- 2,506
- 910
- WACC
- 13.0%
- 8.16%
Income statement (TTM)Industry
- Pretax Income
- -$485.90M
- -$575.82K
Balance sheetIndustry
- Net Cash (Debt)
- $1.03B
- $119.40K
- Net Cash Per Share
- $7.65
- $0.00
- Equity (Book Value)
- -$275.90M
- $235.60M
- Book Value Per Share
- -$2.06
- $3.91
- Tangible Book Value
- -$378.15M
- $1.59M
- Working Capital
- $970.24M
- $30.06M
Cash flow (TTM)Industry
- Capital Expenditures
- -$58.67M
- -$15.83M
- FCF Per Share
- -$1.73
- $0.36
Dividends and yieldsIndustry
- Earnings Yield
- -2.33%
- 0.25%
- FCF Yield
- -1.12%
- 2.58%
- Buyback Yield
- 0.00%
- 0.99%
- Shareholder Yield
- 0.00%
- 1.58%
Taxes and interestIndustry
- Interest Expense
- $5.22M
- $7.37M
- Income Tax
- -$827.00K
- $564.50K
Scores and fair valueIndustry
- Altman Z-Score
- 3.69
- 2.24
- Piotroski F-Score
- 6
- 5
- Beneish M-Score
- -2.79
- -2.76
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | GH | S&P 500 | Difference | GH per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -4.9% | -2.7% | −2.2 pts | ||
| 3 months | -6.2% | -1.7% | −4.5 pts | ||
| Year to date | +51.6% | +11.9% | +39.7 pts | ||
| 1 year | +58.3% | +12.0% | +46.3 pts | ||
| 3 years | +617.6% | +78.2% | +539.4 pts | +92.9% | +21.2% |
| 5 years | +49.2% | +73.2% | −24.0 pts | +8.3% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
9M GH shares were sold short on Oct 30, 2026, down 19.2% from the previous report, or 7.16% of the shares available to trade. At recent volumes it would take 5.4 days to buy them back. Over the last 20 sessions, 48.1% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 9,433,137 | -19.2% | 1,752,636 | 5.4 |
| Oct 15, 2026 | 11,668,451 | -2.1% | 1,745,274 | 6.7 |
| Sep 30, 2026 | 11,915,002 | +8.1% | 1,920,986 | 6.2 |
| Sep 15, 2026 | 11,018,331 | -0.3% | 1,671,340 | 6.6 |
| Aug 31, 2026 | 11,050,208 | -1.3% | 2,104,230 | 5.3 |
| Aug 14, 2026 | 11,191,601 | -2.0% | 1,950,524 | 5.7 |
| Jul 31, 2026 | 11,416,103 | -0.0% | 2,118,220 | 5.4 |
| Jul 15, 2026 | 11,421,015 | -5.9% | 2,820,046 | 4.0 |
| Jun 30, 2026 | 12,141,165 | -7.2% | 4,249,397 | 2.9 |
| Jun 15, 2026 | 13,087,255 | -0.9% | 2,051,741 | 6.4 |
| May 29, 2026 | 13,207,298 | +2.1% | 2,934,093 | 4.5 |
| May 15, 2026 | 12,930,341 | +1.0% | 1,827,618 | 7.1 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?